{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:09:22Z","timestamp":1762459762404,"version":"build-2065373602"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,6]]},"DOI":"10.7759\/cureus.96244","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:01:52Z","timestamp":1762459312000},"source":"Crossref","is-referenced-by-count":0,"title":["Rifampin Use in Staphylococcal Prosthetic Joint Infections"],"prefix":"10.7759","author":[{"given":"Kunjan","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B","family":"Baladad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaina S","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"DeSear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon DR","year":"2013","unstructured":"Osmon DR, Berbari EF, Berendt AR, et al.. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013, 56:e1-e25. 10.1093\/cid\/cis803","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.N.01141","article-title":"Prevalence of total hip and knee replacement in the United States","volume":"97","author":"Maradit Kremers H","year":"2015","unstructured":"Maradit Kremers H, Larson DR, Crowson CS, et al.. Prevalence of total hip and knee replacement in the United States. J Bone Joint Surg Am. 2015, 97:1386-97. 10.2106\/JBJS.N.01141","journal-title":"J Bone Joint Surg Am"},{"key":"ref3","article-title":"HCUP Projections: mobility\/ orthopedic procedures 2003 to 2012. HCUP Projections Report # 2012-03","author":"Steiner C","year":"2014","unstructured":"Steiner C, Andrews R, Barrett M, Weiss A. HCUP Projections: mobility\/ orthopedic procedures 2003 to 2012. HCUP Projections Report # 2012-03. U.S. Agency for Healthcare Research and Quality, Rockville, MD; 2014."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040181","article-title":"Prosthetic-joint infections","volume":"351","author":"Zimmerli W","year":"2004","unstructured":"Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004, 351:1645-54. 10.1056\/NEJMra040181","journal-title":"N Engl J Med"},{"key":"ref5","article-title":"National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data","author":"Kozak LJ","year":"2006","unstructured":"Kozak LJ, DeFrances CJ, Hall MJ. National Hospital Discharge Survey: 2004 Annual Summary With Detailed Diagnosis and Procedure Data. National Center for Health Statistics, Hyattsville, MD; 2006. https:\/\/www.cdc.gov\/nchs\/data\/series\/sr_13\/sr13_162.pdf."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1086\/374554","article-title":"Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists","volume":"36","author":"Lentino JR","year":"2003","unstructured":"Lentino JR. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis. 2003, 36:1157-61. 10.1086\/374554","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s1521-6942(03)00002-0","article-title":"Infection and arthritis. Infection of prosthetic joints","volume":"17","author":"Lidgren L","year":"2003","unstructured":"Lidgren L, Knutson K, Stef\u00e1nsd\u00f3ttir A. Infection and arthritis. Infection of prosthetic joints. Best Pract Res Clin Rheumatol. 2003, 17:209-18. 10.1016\/s1521-6942(03)00002-0","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref8","article-title":"Evaluation and treatment of infection at the site of a total hip or knee arthroplasty","volume":"48","author":"Hanssen AD","year":"1999","unstructured":"Hanssen AD, Rand JA. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr Course Lect. 1999, 48:111-22.","journal-title":"Instr Course Lect"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-020-01877-2","article-title":"Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial","volume":"15","author":"Karlsen \u00d8E","year":"2020","unstructured":"Karlsen \u00d8E, Borgen P, Bragnes B, et al.. Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial. J Orthop Surg Res. 2020, 15:365. 10.1186\/s13018-020-01877-2","journal-title":"J Orthop Surg Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2022.02.050","article-title":"Prosthetic knee infection with coagulase-negative Staphylococcus: a harbinger of poor outcomes","volume":"37","author":"Charalambous LT","year":"2022","unstructured":"Charalambous LT, Kim BI, Schwartz AM, et al.. Prosthetic knee infection with coagulase-negative Staphylococcus: a harbinger of poor outcomes. J Arthroplasty. 2022, 37:S313-20. 10.1016\/j.arth.2022.02.050","journal-title":"J Arthroplasty"},{"key":"ref11","article-title":"M100 Performance Standards for Antimicrobial Susceptibility Testing USA.9781684401352","year":"2025","unstructured":"CLSI M100. Performance Standards for Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute, Malvern, PA; 2025. https:\/\/clsi.org\/shop\/standards\/m100\/."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2022.03.072","article-title":"The use of rifampin in total joint arthroplasty: a systematic review and meta-analysis of comparative studies","volume":"37","author":"Kruse CC","year":"2022","unstructured":"Kruse CC, Ekhtiari S, Oral I, et al.. The use of rifampin in total joint arthroplasty: a systematic review and meta-analysis of comparative studies. J Arthroplasty. 2022, 37:1650-7. 10.1016\/j.arth.2022.03.072","journal-title":"J Arthroplasty"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab426","article-title":"If, when, and how to use rifampin in acute staphylococcal periprosthetic joint infections, a multicentre observational study","volume":"73","author":"Beldman M","year":"2021","unstructured":"Beldman M, L\u00f6wik C, Soriano A, et al.. If, when, and how to use rifampin in acute staphylococcal periprosthetic joint infections, a multicentre observational study. Clin Infect Dis. 2021, 73:1634-41. 10.1093\/cid\/ciab426","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac473","article-title":"Effectiveness and optimal duration of adjunctive rifampin treatment in the management of Staphylococcus aureus prosthetic joint infections after debridement, antibiotics, and implant retention","volume":"9","author":"Suzuki H","year":"2022","unstructured":"Suzuki H, Goto M, Nair R, et al.. Effectiveness and optimal duration of adjunctive rifampin treatment in the management of Staphylococcus aureus prosthetic joint infections after debridement, antibiotics, and implant retention. Open Forum Infect Dis. 2022, 9:ofac473. 10.1093\/ofid\/ofac473","journal-title":"Open Forum Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac363","article-title":"Truth in DAIR: duration of therapy and the use of quinolone\/rifampin-based regimens after debridement and implant retention for periprosthetic joint infections","volume":"9","author":"Tai DB","year":"2022","unstructured":"Tai DB, Berbari EF, Suh GA, Lahr BD, Abdel MP, Tande AJ. Truth in DAIR: duration of therapy and the use of quinolone\/rifampin-based regimens after debridement and implant retention for periprosthetic joint infections. Open Forum Infect Dis. 2022, 9:ofac363. 10.1093\/ofid\/ofac363","journal-title":"Open Forum Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz261","article-title":"Benefits and adverse events associated with extended antibiotic use in total knee arthroplasty periprosthetic joint infection","volume":"70","author":"Shah NB","year":"2020","unstructured":"Shah NB, Hersh BL, Kreger A, et al.. Benefits and adverse events associated with extended antibiotic use in total knee arthroplasty periprosthetic joint infection. Clin Infect Dis. 2020, 70:559-65. 10.1093\/cid\/ciz261","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/376298-rifampin-use-in-staphylococcal-prosthetic-joint-infections","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:01:53Z","timestamp":1762459313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/376298-rifampin-use-in-staphylococcal-prosthetic-joint-infections"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.96244","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,6]]}}}